Page last updated: 2024-12-06

fluridone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Fluridone is a herbicide that inhibits carotenoid biosynthesis in plants. It is used to control weeds in rice, sugarcane, and other crops. Fluridone is synthesized by a multi-step process that involves the reaction of 2,4-dinitrochlorobenzene with 2-methyl-5-nitroaniline. Fluridone is a highly effective herbicide and has been shown to be effective in controlling a wide range of weed species. It is also relatively safe for use in rice and sugarcane, which are major food crops. Fluridone is studied because it is an important herbicide for controlling weeds in rice and sugarcane. It is also a useful tool for studying the role of carotenoids in plant growth and development. Fluridone has been shown to be effective in controlling a wide range of weed species, including barnyardgrass, foxtail, and watergrass. It is also relatively safe for use in rice and sugarcane, which are major food crops.'

Cross-References

ID SourceID
PubMed CID43079
CHEMBL ID1887342
CHEBI ID82016
SCHEMBL ID54579
MeSH IDM0061038

Synonyms (58)

Synonym
pride
sonar
fluridone
4(1h)-pyridinone, 1-methyl-3-phenyl-5-[3-(trifluoromethyl)phenyl]-
1-methyl-3-phenyl-5-(3-(trifluoromethyl)phenyl)-4-pyridone
1-methyl-3-phenyl-5-(alpha,alpha,alpha-trifluoro-m-tolyl)-4-pyridone
4(1h)-pyridinone, 1-methyl-3-phenyl-5-(3-(trifluoromethyl)phenyl)-
brn 1547990
einecs 261-916-6
1-methyl-3-phenyl-5-(3-(trifluoromethyl)phenyl)-4(1h)-pyridinone
brake
el-171
fluridone [ansi:bsi:iso]
hsdb 6653
caswell no. 130c
el 171
epa pesticide chemical code 112900
NCGC00164295-01
1-methyl-3-phenyl-5-[3-(trifluoromethyl)phenyl]pyridin-4(1h)-one
59756-60-4
1-methyl-3-phenyl-5-[3-(trifluoromethyl)phenyl]pyridin-4-one
NCGC00164295-02
NCGC00164295-03
C18857
cas-59756-60-4
dtxsid8024107 ,
tox21_300200
dtxcid404107
NCGC00259711-01
tox21_202162
NCGC00254102-01
3l0jqa61jx ,
unii-3l0jqa61jx
5-21-09-00264 (beilstein handbook reference)
fluridon
FT-0608061
AKOS015903233
fluridone [iso]
fluridone [hsdb]
avast
1-methyl-3-phenyl-5-(.alpha.,.alpha.,.alpha.-trifluoro-m-tolyl)-4-pyridone
SCHEMBL54579
CHEBI:82016 ,
AM85839
CHEMBL1887342
1-methyl-3-phenyl-5-(3-trifluoromethylphenyl)-pyridin-4(1h)-one
1-methyl-3-phenyl-5-[3-(trifluoromethyl)phenyl]-4(1h)-pyridinone #
fluridon, pestanal(r), analytical standard
mfcd00078682
1-methyl-3-phenyl-5-(3-(trifluoromethyl)phenyl)pyridin-4(1h)-one
SY238237
F14118
3-(3-(trifluoromethyl)phenyl)-1-methyl-5-phenylpyridin-4(1h)-one
Q1434245
MS-24940
HY-134094
CS-0138017
1-methyl-3-phenyl-5-[3-(trifluoromethyl)phenyl]-1,4-dihydropyridin-4-one

Research Excerpts

Overview

Fluridone is an active ingredient in aquatic herbicides used globally to control aquatic plants. It is a systemic herbicide used to control a range of invasive aquatic plants in irrigation systems, lake, and reservoirs.

ExcerptReferenceRelevance
"Fluridone is an active ingredient in aquatic herbicides used globally to control aquatic plants."( Effects of subchronic exposure to environmentally relevant concentrations of a commercial fluridone formulation on fathead minnows (Pimephales promelas).
Cozzola, AJ; Dehnert, GK; Karasov, WH; White, AM, 2022
)
1.66
"Fluridone is a systemic herbicide used to control a range of invasive aquatic plants in irrigation systems, lake, and reservoirs. "( Exposure to the herbicide fluridone induces cardiovascular toxicity in early developmental stages of zebrafish.
An, G; Hong, T; Lim, W; Park, H; Park, S; Song, G, 2023
)
2.65
"Fluridone is a herbicide extensively utilized in agriculture for its documented safety in animals. "( Fluridone as a new anti-inflammatory drug.
Bruzzone, S; Cuzzocrea, S; De Flora, A; Di Paola, R; Guida, L; Magnone, M; Salis, A; Scarfì, S; Sturla, L; Zocchi, E, 2013
)
3.28

Treatment

Fluridone and copper treatments elicited different responses within the phytoplankton community. Treatment of flurid one, an ABA biosynthesis inhibitor caused membrane lipid peroxidation and lowered melatonin-induced antioxidant defense responses.

ExcerptReferenceRelevance
"Fluridone and copper treatments elicited different responses within the phytoplankton community."( Ecological impacts of fluridone and copper sulphate in catfish aquaculture ponds.
Culver, DA; Jacob, AP; Lanno, RP; Voigt, A, 2016
)
1.47
"The fluridone treatment caused an increase in the rate of ethylene evolution from intact seedlings."( Abscisic acid accumulation maintains maize primary root elongation at low water potentials by restricting ethylene production.
Bernstein, N; LeNoble, ME; Samuels, TD; Sharp, RE; Spollen, WG, 2000
)
0.79
"Treatment of fluridone, an ABA biosynthesis inhibitor caused membrane lipid peroxidation and lowered melatonin-induced antioxidant defense responses."( Improved cold tolerance in Elymus nutans by exogenous application of melatonin may involve ABA-dependent and ABA-independent pathways.
Fu, J; Hu, T; Liu, Q; Miao, Y; Sun, H; Wang, J; Wu, Y; Xu, Y; Xue, Y; Zhao, E, 2017
)
0.81
"Pre-treatment with fluridone significantly suppressed the NaCl-induced increases, but only slightly delayed the increases in tissue subjected to exogenous ABA treatment."( Involvement of abscisic acid-dependent and -independent pathways in the upregulation of antioxidant enzyme activity during NaCl stress in cotton callus tissue.
Banks, SW; Bellaire, BA; Braud, J; Carmody, J; Fowler, TE; Gossett, DR; Lucas, MC, 2000
)
0.63

Toxicity

ExcerptReferenceRelevance
" Our previous study revealed that the adult stage of Delta Smelt showed acute and sub-lethal adverse effects following 6 h of exposure to environmentally relevant concentrations of fluridone."( Toxic effects of fluridone on early developmental stages of Japanese Medaka (Oryzias latipes).
Hammock, BG; Jin, J; Kurobe, T; Lam, CH; Lin, L; Teh, SJ, 2020
)
1.09

Dosage Studied

ExcerptRelevanceReference
" miltiorrhiza; ABA induced the accumulation of caffeic acid considerably, and the effect on the contents of coffee acid show positive correlation; As for the RA and LAB, the low dosage of ABA simulated the production and higher ABA inhibited the production of them; the ABA biosynthetic inhibitor fluridone can decreases ABA's the effect; The different of ABA activated the activity of PAL and TAT, but the impact were discriminating, when treatment with ABA and fluridone, the inducing were declined."( [Effects of ABA and its biosynthetic inhibitor fluridone on accumulation of penolic acids and activity of PAL and TAT in hairy root of Salvia miltiorrhiza].
Cui, B; Liang, Z; Liu, F; Liu, Y; Zhu, J, 2012
)
0.81
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
carotenoid biosynthesis inhibitorAny pathway inhibitor that acts on the carotenoid biosynthesis pathway.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
phenylpyridine
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (14)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
LuciferasePhotinus pyralis (common eastern firefly)Potency69.30400.007215.758889.3584AID1224835
RAR-related orphan receptor gammaMus musculus (house mouse)Potency19.97790.006038.004119,952.5996AID1159523
GLI family zinc finger 3Homo sapiens (human)Potency27.48720.000714.592883.7951AID1259369; AID1259392
AR proteinHomo sapiens (human)Potency43.73280.000221.22318,912.5098AID743035; AID743042; AID743054; AID743063
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency66.91900.000657.913322,387.1992AID1259377
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency7.31480.001022.650876.6163AID1224838; AID1224893
progesterone receptorHomo sapiens (human)Potency59.64160.000417.946075.1148AID1346795
retinoid X nuclear receptor alphaHomo sapiens (human)Potency8.37120.000817.505159.3239AID1159527; AID1159531; AID588544
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency26.45960.001530.607315,848.9004AID1224841; AID1224848; AID1224849; AID1259403
pregnane X nuclear receptorHomo sapiens (human)Potency23.16920.005428.02631,258.9301AID1346982; AID720659
estrogen nuclear receptor alphaHomo sapiens (human)Potency53.15560.000229.305416,493.5996AID743079
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency44.66840.001024.504861.6448AID588534
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency44.66840.023723.228263.5986AID588541
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency60.87260.000323.4451159.6830AID743065; AID743067
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (102)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (5.88)18.7374
1990's7 (6.86)18.2507
2000's34 (33.33)29.6817
2010's46 (45.10)24.3611
2020's9 (8.82)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 30.49

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index30.49 (24.57)
Research Supply Index4.68 (2.92)
Research Growth Index4.98 (4.65)
Search Engine Demand Index75.05 (26.88)
Search Engine Supply Index3.90 (0.95)

This Compound (30.49)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (1.87%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other105 (98.13%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]